HonorHealth Specialty Pharmacy assists patients with specialty medications. We’re experts when it comes to not only understanding the medications, but also with benefits investigation, prior authorization requirements and financial assistanceLEARN MORE
An update from Craig Norquist, MD, chief medical information officer and Nina Shah, DO, chief quality and clinical value officer: HonorHealth is transitioning to a single standardized chemistry lab assayLEARN MORE
The HonorHealth Specialty Pharmacy is excited to share that they have moved to a newly designed and larger space. As of Jan. 29, the pharmacy is no longer located onLEARN MORE
The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to provide options for clinicians to protect infants from respiratory syncytial virus (RSV)LEARN MORE
Patients needing extra help with complex medication regimens? Not meeting medication-related quality measures? Support your patients with a collaborative practice model of care with our ambulatory clinical pharmacy – HonorHealthLEARN MORE
Situation Patients with coagulation disorders undergoing surgery often require administration of factor products before or after surgery to prevent post-operative complications, such as bleeding. An opportunity exists to identify theseLEARN MORE
As you know, drug shortages can occur for many reasons, including manufacturing and quality problems, delays and discontinuations. Our goal is to keep you informed about any issues we areLEARN MORE
As of Thursday, Jan. 26, 2023, the Federal Drug Administration (FDA) has withdrawn Emergency Use Authorization (EUA) for tixagevimab/cilgavimab (EVUSHELD®) secondary to reduced susceptibility to currently circulating COVID-19 variants. HealthLEARN MORE
A summary of the literature to date on Paxlovid, by Stephanie Schneck, PharmD, system clinical pharmacy director Please follow this link below to read the overview on NIRMATRELVIR/RITONAVIR, including theLEARN MORE
Injectable promethazine is considered a high-risk medication that can contribute to serious tissue injury and amputation if extravasation occurs. The removal of injectable promethazine from hospital formularies has been anLEARN MORE
